Companies Directory

BiosYnth Research Laboratories is a biotech Company focused on the discovery of novel synthetic and semi-synthetic molecules for application as human vaccines in the prevention of serious bacterial diseases like Invasive Pneumococcal Diseases (IPD) and Bacterial Meningitis due to pneumococcal and meningococcal infections. The Company was founded in 1988 by Dr. Massimo Porro on the basis of his pioneering activity in the design and industrial development of CRM 197-based glycoconjugate vaccines for the prevention of bacterial meningitis in infants and young children due to Gram-negative and Gram-positive encapsulated bacteria. Some of these glycoconjugate vaccines, which involved the non-toxic mutant diphtheria protein CRM197 covalently linked to capsular polysaccharides and oligosaccharides derived from the capsule of Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae, are now manufactured and marketed in USA and Europe by two major vaccine producers. The Company’s commercial strategy is that of Licensing third Parties with its proprietary know-how, protected by a technological body of several International Patents, including USA and Europe, relative to the molecular entities designed and developed as vaccines for diseases having broad impact in the public health. The Licensing strategy includes the Technology Transfer of the production processes and the technical assistance for implementing the large-scale production processes. Several cooperations have been implemented in the past more than two decades with the most renowned Companies of the western world producing vaccines for human use. Since the year 2008, a new broad cooperation has been opened in the territory of the P.R. of China for producing polyvalent meningococcal and pneumococcal glycoconjugate vaccines with a modern technology but at an affordable price for the paediatric population of that country.

Regenerative Medicine: How can we grow back a disabled organ ? The key is to find a way to induce organ and tissue regeneration regenerative medicine involves the regrowth of organs at the anatomical site of an adult where the function of original organ has been lost, either due to chronic insult, accidental trauma or elective surgery BioSystOmics is a non-profit organization: We are involved in Translational Research. Our goal is to stimulate the discovery and development of novel regenerative therapies & new drug targets. We are developing enabling tools and technologies for regenerative medicine & target identification & development. Our vision is to develop and introduce rational therapeutic & drug development strategies for the translation of novel cocktails & novel molecular entities as new drugs. Our research platforms will systematically reduce the cost of development. We work at the interface of pharmacology, molecular biology, systems biology and mathematical modeling.

BioTE® Medical is committed to excellence in educating doctors and patients about bio-identical hormone pellet therapy. BioTE® Medical is headquartered in Irving, Texas, with thousands of certified medical practitioners providing pellet therapy nationwide. BioTE® was founded by physicians and is passionate about teaching how hormone balance can be a catalyst for good health. BioTE Medical LLC, has neither sought nor obtained FDA approval for any or all products utilized in the BioTE method of Hormone Optimization. BioTE® was founded by physicians and is passionate about teaching how hormone balance can be a catalyst for good health. BioTE Medical LLC, has neither sought nor obtained FDA approval for any or all products utilized in the BioTE method of Hormone Optimization.

BIOTEC CHILE S.A. es una compañía chilena con dos líneas de negocios: Consumo Masivo e Higiene Profesional. En ambas divisiones, buscamos satisfacer las necesidades de nuestros clientes, a través del entendimiento de sus necesidades, la innovación y por sobretodo, el servicio hacia el cliente. El negocio de HIGIENE PROFESIONAL, tiene como misión crear espacios seguros y sanos para la industria y las personas, asegurando tanto la calidad de los alimentos como de las instalaciones para su uso seguro. En Biotec, contamos con líneas de detergentes, limpiadores, desinfectantes y otros productos para el área industrial. Contáctanos para ayudarte!

Biotec Pharmacon is a public Norwegian group within the biotechnology sector operating through two active subsidiaries, Biotec BetaGlucans AS and ArcticZymes AS. Biotec BetaGlucans develops and manufactures immune modulating compounds for the human health sectors. The company is spearheading research on products that may prevent or treat diseases caused by failure, imbalance and over-reaction of the immune system. ArcticZymes develops and manufactures heat labile marine enzymes used in molecular biology and diagnostics aiming at OEM customers worldwide. Biotec Pharmacon group is connected to BioTech North, a biotechnology cluster based in Tromsø.

Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Our community helps catalyse early stage innovation through peer-to-peer education and knowledge sharing, networking, partnering and deal making to champion the most innovative and exciting ideas. We bring deals to life.

BioTech Annecto is a social networking organization, whose aim is to bring together entrepreneurs, investors, scientists, attorneys, journalists and other professionals in the biotechnology sector: pharmaceutical, healthcare and biomedical, cosmetics, and environment. Launched February 2009 in Montreal (Quebec, Canada), BioTech Annecto (previously known as BioTech Montreal) is inviting people, one Tuesday every month, from the Montreal biotechnology community to meet at trendy locations around town. Members come from the business world, from public agencies as well as academic institutions. This allows regular communication and exchanges between industry, the public sector and academia. BioTech Annecto has had, besides Montreal, chapters in Toronto, Ottawa, and Vancouver.

Biotech Connection Singapore is part of an international network of non-profit organizations that aims to promote the transfer of ideas from theory to real world applications by providing a platform for fostering interaction between academia, industry and businesses. We aim to connect innovators with each other and industry resources to help you get the support necessary to conceptualize, develop and commercialize technology & research. Our engagement with the community occurs via three ways: education, consulting and communications. Join us today to access our global network of bio-entrepreneurs, seed funding and industry support.